Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Antibody Drug Conjugates Market Report by Component (Monoclonal Antibodies, Linker, Cytotoxic Agent, and Others), Target (Antibody-Protein Toxin Conjugates, Antibody-Chelated Radionuclide Conjugates, Antibody-Small-Molecule Drug Conjugates, Antibody-Enzyme Conjugates), Application (Lymphoma, Ovarian Cancer, Lung Cancer, Breast Cancer, Brain Tumor, and Others), End User (Hospitals, Specialized Cancer Centers, Academic Research Institutes, Biotechnology Companies, and Others), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A4604
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Antibody Drug Conjugates Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Component
6.1 Monoclonal Antibodies
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Linker
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Cytotoxic Agent
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Target
7.1 Antibody-Protein Toxin Conjugates
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Antibody-Chelated Radionuclide Conjugates
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Antibody-Small-Molecule Drug Conjugates
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Antibody-Enzyme Conjugates
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Application
8.1 Lymphoma
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ovarian Cancer
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Lung Cancer
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Breast Cancer
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Brain Tumor
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Specialized Cancer Centers
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Academic Research Institutes
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Biotechnology Companies
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 ADC Therapeutics SA
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.2 Astellas Pharma Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 AstraZeneca plc
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Celldex Therapeutics Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 F. Hoffmann-La Roche AG
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.6 Gilead Sciences Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 GlaxoSmithKline Plc
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 ImmunoGen Inc
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Pfizer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sanofi S.A.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Seagen Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Sorrento Therapeutics Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.13 Takeda Pharmaceutical Company Ltd.
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.13.3 Financials
15.3.13.4 SWOT Analysis
List of Figures
Figure 1: Global: Antibody Drug Conjugates Market: Major Drivers and Challenges
Figure 2: Global: Antibody Drug Conjugates Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Antibody Drug Conjugates Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Antibody Drug Conjugates Market: Breakup by Component (in %), 2023
Figure 5: Global: Antibody Drug Conjugates Market: Breakup by Target (in %), 2023
Figure 6: Global: Antibody Drug Conjugates Market: Breakup by Application (in %), 2023
Figure 7: Global: Antibody Drug Conjugates Market: Breakup by End User (in %), 2023
Figure 8: Global: Antibody Drug Conjugates Market: Breakup by Region (in %), 2023
Figure 9: Global: Antibody Drug Conjugates (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Antibody Drug Conjugates (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Antibody Drug Conjugates (Linker) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Antibody Drug Conjugates (Linker) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Antibody Drug Conjugates (Cytotoxic Agent) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Antibody Drug Conjugates (Cytotoxic Agent) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Antibody Drug Conjugates (Other Components) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Antibody Drug Conjugates (Other Components) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Antibody Drug Conjugates (Antibody-Protein Toxin Conjugates) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Antibody Drug Conjugates (Antibody-Protein Toxin Conjugates) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Antibody Drug Conjugates (Antibody-Chelated Radionuclide Conjugates) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Antibody Drug Conjugates (Antibody-Chelated Radionuclide Conjugates) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Antibody Drug Conjugates (Antibody-Small-Molecule Drug Conjugates) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Antibody Drug Conjugates (Antibody-Small-Molecule Drug Conjugates) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Antibody Drug Conjugates (Antibody-Enzyme Conjugates) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Antibody Drug Conjugates (Antibody-Enzyme Conjugates) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Antibody Drug Conjugates (Lymphoma) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Antibody Drug Conjugates (Lymphoma) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Antibody Drug Conjugates (Ovarian Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Antibody Drug Conjugates (Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Antibody Drug Conjugates (Lung Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Antibody Drug Conjugates (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Antibody Drug Conjugates (Breast Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Antibody Drug Conjugates (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Antibody Drug Conjugates (Brain Tumor) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Antibody Drug Conjugates (Brain Tumor) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Antibody Drug Conjugates (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Antibody Drug Conjugates (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Antibody Drug Conjugates (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Antibody Drug Conjugates (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Global: Antibody Drug Conjugates (Specialized Cancer Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Global: Antibody Drug Conjugates (Specialized Cancer Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Global: Antibody Drug Conjugates (Academic Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Global: Antibody Drug Conjugates (Academic Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Global: Antibody Drug Conjugates (Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Global: Antibody Drug Conjugates (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Global: Antibody Drug Conjugates (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Global: Antibody Drug Conjugates (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: North America: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: North America: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: United States: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: United States: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Canada: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Canada: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Asia-Pacific: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Asia-Pacific: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: China: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: China: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Japan: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Japan: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: India: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: India: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: South Korea: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: South Korea: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Australia: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Australia: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Indonesia: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Indonesia: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Others: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Others: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Europe: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Europe: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Germany: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Germany: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: France: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: France: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: United Kingdom: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: United Kingdom: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Italy: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Italy: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Spain: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Spain: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Russia: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Russia: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Others: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Others: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Latin America: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: Latin America: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Brazil: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 88: Brazil: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 89: Mexico: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 90: Mexico: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 91: Others: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 92: Others: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 93: Middle East and Africa: Antibody Drug Conjugates Market: Sales Value (in Million US$), 2018 & 2023
Figure 94: Middle East and Africa: Antibody Drug Conjugates Market: Breakup by Country (in %), 2023
Figure 95: Middle East and Africa: Antibody Drug Conjugates Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 96: Global: Antibody Drug Conjugates Industry: SWOT Analysis
Figure 97: Global: Antibody Drug Conjugates Industry: Value Chain Analysis
Figure 98: Global: Antibody Drug Conjugates Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Antibody Drug Conjugates Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Antibody Drug Conjugates Market Forecast: Breakup by Component (in Million US$), 2024-2032
Table 3: Global: Antibody Drug Conjugates Market Forecast: Breakup by Target (in Million US$), 2024-2032
Table 4: Global: Antibody Drug Conjugates Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Antibody Drug Conjugates Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: Antibody Drug Conjugates Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Antibody Drug Conjugates Market: Competitive Structure
Table 8: Global: Antibody Drug Conjugates Market: Key Players
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More